Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies

por Husain, Bushra, Ellerman, Diego
Publicado 2018

Contribution of dsRBD2 to PKR Activation

por Hesler, Stephen, Angeliadis, Matthew, Husain, Bushra, Cole, James L.
Publicado 2021

Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike

por Husain, Bushra, Yuen, Kobe, Sun, Dawei, Cao, Shengya, Payandeh, Jian, Martinez-Martin, Nadia
Publicado 2022

The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology

por Astarita, Jillian L., Keerthivasan, Shilpa, Husain, Bushra, Şenbabaoğlu, Yasin, Verschueren, Erik, Gierke, Sarah, Pham, Victoria C., Peterson, Sean M., Chalouni, Cecile, Pierce, Andrew A., Lill, Jennie R., Gonzalez, Lino C., Martinez-Martin, Nadia, Turley, Shannon J.
Publicado 2021

Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal Cancer

por Wang, Peiyin, Sun, Liping L., Clark, Robyn, Hristopoulos, Maria, Chiu, Cecilia P.C., Dillon, Michael, Lin, WeiYu, Lo, Amy A., Chalsani, Sreedevi, Das Thakur, Meghna, Zimmerman Savill, Kristin M., Rougé, Lionel, Lupardus, Patrick, Piskol, Robert, Husain, Bushra, Ellerman, Diego, Shivva, Vittal, Leong, Steven R., Ovacik, Meric, Totpal, Klara, Wu, Yan, Spiess, Christoph, Lee, Genee, Leipold, Douglas D., Polson, Andrew G.
Publicado 2022